Niihara Yutaka's Form 4 filing
Emmaus Life Sciences, Inc. (EMMA) · filed Oct 17, 2022
- Accession no.
- 0001209191-22-053757
- Filed
- Oct 17, 2022, 1:01 PM ET
- Trade date
- Oct 13-14, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $17.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Niihara YutakaCIK 0001517691 | Director, Officer (Chairman and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +62,500 | $0.18 | +$11,250 | 11,746,357 | Direct | |
| Oct 14, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +35,000 | $0.17 | +$5,950 | 11,781,357 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.